Can 18 F-FDG-Positron Emission Tomography be a Prognostic Tool in Children With Rhabdomyosarcoma Treated With Definitive Radiotherapy?

Badira Cheriyalinkal Parambil,Sneha Shah,Maya Prasad,Tushar Vora,Siddhartha Laskar,Nehal Khanna,Sajid Qureshi,Mukta Ramadwar,Seema Kembhavi,Hari Sankaran,Venkatesh Rangarajan,Sonali Thakur,Girish Chinnaswamy

Journal of pediatric hematology/oncology（2023）

引用 1|浏览12

暂无评分

摘要

Persistent metabolic activity in residual disease post-chemoradiotherapy in RMS may portend a poorer prognosis with an increased risk of relapse. This subset of high-risk patients needs to be identified, and further trials are warranted to develop strategies to improve their outcomes.

查看译文

关键词

FDG-PET, rhabdomyosarcoma, FDG-avid residual, definitive radiotherapy, prognosis

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要